1-6 of 6
Mitsuhiro Takenoyama
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase I Study of the Anti-CC Chemokine Receptor 4 Antibody, Mogamulizumab, in Combination with Nivolumab in Patients with Advanced or Metastatic Solid Tumors

Toshihiko Doi, Kei Muro, Hiroshi Ishii, Terufumi Kato, Takahiro Tsushima, Mitsuhiro Takenoyama, Satoshi Oizumi, Kazuto Gemmoto, Hideaki Suna, Kouki Enokitani, Tetsuyoshi Kawakami, Hiroyoshi Nishikawa, Noboru Yamamoto
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (22): 6614–6622.
https://doi.org/10.1158/1078-0432.CCR-19-1090
Published: 15 November 2019
View article titled, A Phase I Study of the Anti-CC Chemokine Receptor 4 Antibody, Mogamulizumab, in Combination with Nivolumab in Patients with Advanced or Metastatic Solid Tumors
Open the PDF for A Phase I Study of the Anti-CC Chemokine Receptor 4 Antibody, Mogamulizumab, in Combination with Nivolumab in Patients with Advanced or Metastatic Solid Tumors in another window
Includes: Supplementary data
Journal Articles

Clinical Efficacy and Safety of Nivolumab: Results of a M ulticenter, Op e n-label, Single-a r m, Japanese Phase II study in Mal i gnant Pleural Meso t helioma (MERIT)

Morihito Okada, Takashi Kijima, Keisuke Aoe, Terufumi Kato, Nobukazu Fujimoto, Kazuhiko Nakagawa, Yuichiro Takeda, Toyoaki Hida, Kuninobu Kanai, Fumio Imamura, Satoshi Oizumi, Toshiaki Takahashi, Mitsuhiro Takenoyama, Hiroshi Tanaka, Jun Hirano, Yoshinobu Namba, Yuichiro Ohe
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2019) 25 (18): 5485–5492.
https://doi.org/10.1158/1078-0432.CCR-19-0103
Published: 13 September 2019
View article titled, Clinical Efficacy and Safety of Nivolumab: Results of a M ulticenter, Op e n-label, Single-a r m, Japanese Phase II study in Mal i gnant Pleural Meso t helioma (MERIT)
Open the PDF for Clinical Efficacy and Safety of Nivolumab: Results of a M ulticenter, Op e n-label, Single-a r m, Japanese Phase II study in Mal i gnant Pleural Meso t helioma (MERIT) in another window
Includes: Supplementary data
Journal Articles

Prognostic and Therapeutic Implications of Aromatase Expression in Lung Adenocarcinomas with EGFR Mutations

Mikihiro Kohno, Tatsuro Okamoto, Kenichi Suda, Mototsugu Shimokawa, Hirokazu Kitahara, Shinichiro Shimamatsu, Hideyuki Konishi, Tsukihisa Yoshida, Mitsuhiro Takenoyama, Tokujiro Yano, Yoshihiko Maehara
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (13): 3613–3622.
https://doi.org/10.1158/1078-0432.CCR-13-2683
Published: 30 June 2014
View article titled, Prognostic and Therapeutic Implications of Aromatase Expression in Lung Adenocarcinomas with <em>EGFR</em> Mutations
Open the PDF for Prognostic and Therapeutic Implications of Aromatase Expression in Lung Adenocarcinomas with <em>EGFR</em> Mutations in another window
Includes: Supplementary data
Journal Articles

Abstract B13: Non-small cell lung cancer with double driver mutations.

Atsushi Osoegawa, Gouji Toyokawa, Taro Ohba, Michiyo Miyawaki, Masafumi Yamaguchi, Kenichi Taguchi, Takashi Seto, Mitsuhiro Takenoyama, Yukito Ichinose, Kenji Sugio
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (2_Supplement): B13.
https://doi.org/10.1158/1078-0432.14AACRIASLC-B13
Published: 16 January 2014
View article titled, Abstract B13: Non-small cell lung cancer with double driver mutations.
Journal Articles

Significance of Immunohistochemical Expression of Estrogen Receptors α and β in Squamous Cell Carcinoma of the Esophagus

Tadahiro Nozoe, Tsunehiro Oyama, Mitsuhiro Takenoyama, Takeshi Hanagiri, Kenji Sugio, Kosei Yasumoto
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (14): 4046–4050.
https://doi.org/10.1158/1078-0432.CCR-07-0449
Published: 18 July 2007
View article titled, Significance of Immunohistochemical Expression of Estrogen Receptors α and β in Squamous Cell Carcinoma of the Esophagus
Open the PDF for Significance of Immunohistochemical Expression of Estrogen Receptors α and β in Squamous Cell Carcinoma of the Esophagus in another window
Journal Articles

Identification of the HLA-Cw*0702-Restricted Tumor-Associated Antigen Recognized by a CTL Clone from a Lung Cancer Patient

Yoshika Nagata, Takeshi Hanagiri, Mitsuhiro Takenoyama, Takashi Fukuyama, Makiko Mizukami, Tetsuya So, Yoshinobu Ichiki, Masakazu Sugaya, Kenji Sugio, Kosei Yasumoto
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (14): 5265–5272.
https://doi.org/10.1158/1078-0432.CCR-04-2542
Published: 20 July 2005
View article titled, Identification of the HLA-Cw*0702-Restricted Tumor-Associated Antigen Recognized by a CTL Clone from a Lung Cancer Patient
Open the PDF for Identification of the HLA-Cw*0702-Restricted Tumor-Associated Antigen Recognized by a CTL Clone from a Lung Cancer Patient in another window